EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS139-08662 
Organism
Homo sapiens 
Tissue/cell
Myotube 
Coordinate
chr11:9837030-9838060 
TF binding sites/motifs
Number: 3             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
JUN(var.2)MA0489.1chr11:9837472-9837486AAGAGATGACTCAG+6.67
ZNF263MA0528.1chr11:9837060-9837081AGGGCAGGAGGAAGAGAGGGA+6.35
ZNF263MA0528.1chr11:9837066-9837087GGAGGAAGAGAGGGAAGGAAA+7.15
Number of super-enhancer constituents: 6             
IDCoordinateTissue/cell
SE_37183chr11:9836873-9838166HSMMtube
SE_44219chr11:9836907-9838428NHDF-Ad
SE_45197chr11:9837000-9837712NHLF
SE_45779chr11:9835452-9838261Osteoblasts
SE_47204chr11:9836841-9839200Panc1
SE_55915chr11:9835599-9838999u87
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr1198373289837627
Number: 1             
IDChromosomeStartEnd
GH11I009815chr1198370299838082
Enhancer Sequence
TATTGAGGAA GGGCAGACAG AAAGAAAAAG AGGGCAGGAG GAAGAGAGGG AAGGAAAAAG 60
GCAGCATCCC AACTCTTTCT TACTCAAATA CGTATGATCA CATAGCTAAT CTGAGAAATT 120
ATGTGCAAAG AGAATGGCAG AGGGGAGTAT TAAGGAGCTA AACCTCGGAG AGTGATTCGG 180
ATCACGAGTA AGTGTTGTGC TGAAGCATGG AAAGTCTGTG CTCTGGAAAA GACACTGGCA 240
CCAGCAACCC TGGATTGCTG TAGAAAAGGG TTCTATTTTT TGGATATAAA ATTATCTACT 300
GTATCAGAAG ACACATATGC AGATTTAAAA CTTGAGCATT ACCCAGCAGT TTTATGCCCT 360
CTACCCTAAA GGTTAGTGAC TAAGTGGTTG CAGCAGTCCA GGCAGTGGGA GAAGAGCTAG 420
CAAAGCCACT AGCCTGCTCC AGAAGAGATG ACTCAGTTAC TGGCATCTTA AGGGCCAAGC 480
ATGTGGGATC TTGCTAATGG CACCCTGCTC ACAGTTTCTG CTCCACGGTT CAGCCAGAGG 540
TCTGTCTAGG TTGTCCAGTG CCAACTGGAG CACTGGATTA AACGTTGAGA TTTCTGAGTT 600
AACAGATAAC TTTCATGTCC TATATACCTA CTGGTAGTAA TGAAATTTAT TTTGTAATGT 660
GTGACTTGCA AAACATTAAA TTCAAGGAAT TGTTGTTGCT TTTGGAGGAA AAGACCATCT 720
TTACAATTTA TGGGCCCTCA GCATGGTGAA GCTCTTTAGC GCAACAATTT AACAGTAAGA 780
ATAAAGTTGA TTAGCATCTA GTATTTTGAA TTTTCTGACA CATCTTAGGA CATGTGTCTC 840
TTTCTATATA GCTTTGCGAA GTTTTAACAA GTGTTACTCA GAAAACCTAG ACTTGGCCTT 900
GCCTTGCCTC CATACATGGT ACCACAGTCT TCCTCTCTCC ATTCTTCTAT GTTTCTGTAG 960
CCTGCTTTAG GTTTACCATA ACAAAACTAT CTGTTTTGCC ATGGGCAGAT TCCTGTGGAA 1020
ACTGAATCAA 1030